Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyruvate dehydrogenase E1 subunit alpha 2 is a nuclear-encoded, mitochondrial enzyme subunit, encoded by the autosomal, intronless PDHA2 gene. This subunit is part of the E1 enzyme (α2β2 tetramer) in the pyruvate dehydrogenase complex, which catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA—a crucial step linking glycolysis and the citric acid cycle. PDHA2 is expressed predominantly in testis tissue due to gene methylation silencing in somatic cells, and it plays a testis-specific role in cellular energy production[2][4]. Regulation occurs at the level of phosphorylation by pyruvate dehydrogenase kinases and is essential for maintaining proper metabolic flux. Dysfunction of the pyruvate dehydrogenase complex is associated with metabolic diseases, and modulation of its activity is considered for treatments of cancer and metabolic disorders, though PDHA2 is less commonly targeted directly compared to PDHA1[1][4].
Activation of the pyruvate dehydrogenase complex (by inhibition of pyruvate dehydrogenase kinase) Modulation of enzyme phosphorylation (regulating active/inactive states of E1 complex[4])
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase E1 subunit alpha 2 (PDHA2).